Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in Acute Schizophrenic Psychosis
NCT00628290Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Oct 2002
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in schizophrenia, sponsored by University of Cologne. Started Oct 2002; status: completed.
02
Drugs
cannabidiol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00628290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628290.